Evolution of the Quality of Life of Long-Term Fibromyalgia Users of Millimeter Wave-Based Neuromodulation: A Real-World Retrospective Study

Laure Minier,1 Paolo Zanini,1 Emilie Chipon,1 Raphaël Gonon-Demoulian,2 Erwan Treillet,3,4 David Crouzier1 1Medical Research, Remedee Labs, Montbonnot Saint-Martin, France; 2Pain, Psychosomatics and Functional Disease Department, Montpellier University hospital, Montpellier, France; 3Pain Management and Palliative Care Unit, APHP Lariboisière Hospital, Paris, France; 4Pain Management, Colmar Civil Hospital, Colmar, FranceCorrespondence: Emilie Chipon, Remedee Labs, 99 chemin de l’étoile, 38330, Montbonnot Saint-Martin, France, Email [email protected]: Fibromyalgia (FM) is a widespread pain condition, associated with other symptoms such as fatigue, sleep disorders, stiffness, and mood disturbances. It significantly impacts patients’ quality of life (QoL) and poses a substantial challenge due to the lack of a definitive cure. This study aimed to report real-world data on the long-term use (18 months) of a millimeter (MMW)-based neuromodulation device and tracking application, and its effects on various health dimensions in a self-declared FM population.Methods: This retrospective study was based on data including daily MMW wristband use and health parameters assessed at baseline (D0) and tracked weekly (pain, stiffness and fatigue) or quarterly (QoL, quality of sleep and impression of change). The primary inclusion criteria were a self-reported diagnosis of FM and consistent device usage for a minimum of 18 months.Results: The inclusion criteria were met by 185 users. There was a reduction in the Fibromyalgia Impact Questionnaire (FIQ) scores, with an average reduction of 27% after the first three months (M3), indicating improved QoL, and stabilization thereafter. Similar improvements were observed in sleep quality, stiffness and fatigue. In contrast, pain intensity showed a continuous decline throughout the 18-month period.Conclusion: The significant improvements in QoL, pain intensity, and sleep quality, maintained over time, underline the MMW device’s ability to provide sustained relief and enhance daily lives of people with FM.Keywords: fibromyalgia, millimeter-waves, neuromodulation, quality of life, pain

Publication Details

Journal
SHILAP Revista de lepidopterología
Published
2025-03-01
Primary Topic
Laser-Plasma Interactions and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evolution of the Quality of Life of Long-Term Fibromyalgia Users of Millimeter Wave-Based Neuromodulation: A Real-World Retrospective Study

SHILAP Revista de lepidopterología
Laser-Plasma Interactions and Diagnostics
article

Evolution of the Quality of Life of Long-Term Fibromyalgia Users of Millimeter Wave-Based Neuromodulation: A Real-World Retrospective Study

article en

Abstract

Laure Minier,1 Paolo Zanini,1 Emilie Chipon,1 Raphaël Gonon-Demoulian,2 Erwan Treillet,3,4 David Crouzier1 1Medical Research, Remedee Labs, Montbonnot Saint-Martin, France; 2Pain, Psychosomatics and Functional Disease Department, Montpellier University hospital, Montpellier, France; 3Pain Management and Palliative Care Unit, APHP Lariboisière Hospital, Paris, France; 4Pain Management, Colmar Civil Hospital, Colmar, FranceCorrespondence: Emilie Chipon, Remedee Labs, 99 chemin de l’étoile, 38330, Montbonnot Saint-Martin, France, Email [email protected]: Fibromyalgia (FM) is a widespread pain condition, associated with other symptoms such as fatigue, sleep disorders, stiffness, and mood disturbances. It significantly impacts patients’ quality of life (QoL) and poses a substantial challenge due to the lack of a definitive cure. This study aimed to report real-world data on the long-term use (18 months) of a millimeter (MMW)-based neuromodulation device and tracking application, and its effects on various health dimensions in a self-declared FM population.Methods: This retrospective study was based on data including daily MMW wristband use and health parameters assessed at baseline (D0) and tracked weekly (pain, stiffness and fatigue) or quarterly (QoL, quality of sleep and impression of change). The primary inclusion criteria were a self-reported diagnosis of FM and consistent device usage for a minimum of 18 months.Results: The inclusion criteria were met by 185 users. There was a reduction in the Fibromyalgia Impact Questionnaire (FIQ) scores, with an average reduction of 27% after the first three months (M3), indicating improved QoL, and stabilization thereafter. Similar improvements were observed in sleep quality, stiffness and fatigue. In contrast, pain intensity showed a continuous decline throughout the 18-month period.Conclusion: The significant improvements in QoL, pain intensity, and sleep quality, maintained over time, underline the MMW device’s ability to provide sustained relief and enhance daily lives of people with FM.Keywords: fibromyalgia, millimeter-waves, neuromodulation, quality of life, pain

SHILAP Revista de lepidopterología
Reduced inequalities
Openalex Percentile: Top 33%
Laser-Plasma Interactions and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.